Most Recent News

Don't miss daily news

BioSTL Event Helps Bioscience Startups Navigate FDA, IP and Raising Capital

Trying to build a business from scratch is immensely difficult. Between building a product, marketing that product, building business partnerships, hiring the right people, and everything else, there may be.

  • 0
  • 527 views

$100,000 Grant Awarded To BioSTL To Promote Inclusion Of Women And Minorities In Bioscience And Entrepreneurship

There’s a new pilot program in the works from BioSTL thanks to a $100,000 grant they received from the Blackstone Charitable Foundation.  The new program, announced last week, aims to.

  • 0
  • 411 views

Danforth Plant Science Center To Continue Investment In Robotics in 2013

Jim Carrington, the president of the Danforth Plant Science Center in St. Louis, confirmed today that the center will continue to invest in lab procedure automation robots.

  • 0
  • 553 views

Monsanto Ups Its Venture Capital Game To Grow Product Pipeline

St. Louis-based Monsanto aims to get a sneak peek at emerging agricultural technologies by boosting the company’s venture capital arm in 2013. The company signaled its investment-focused ramp up by hiring venture capitalist John Hamer in September who joined the company as investment director of Monsanto Growth Ventures.

  • 0
  • 518 views

SLU Researchers Land $1.8 Million For Lupus Research

Researchers in Saint Louis University’s division of rheumatology in the department of internal medicine will be one step closer to understanding the disease lupus thanks to a $1.8 million grant from the National Institute of Health.

  • 0
  • 503 views

St. Louis’ CORTEX Begins Phase II With $186M Investment

This week CORTEX, a growing technology district in St. Louis, has unveiled Phase II of its 20 year plan to become one of the largest tech hubs in the Midwest.

  • 0
  • 474 views

Kypha Raises $1.5M To Bring Compact Health Diagnosis Tech To Market

St. Louis-based medtech company Kypha has raised nearly $2.5 million over the past year to bring its premier technology, the CompAct test, to the market in 2013.

  • 0
  • 529 views

Confluence Raises $4M To Accelerate Novel Cancer Treatment Research

Confluence, a St. Louis-based biomedical research company, announced that it has secured $4 million in series A venture capital financing this week that will help further the company’s research of kinase inhibitor cancer treatments.

  • 0
  • 558 views